Lumen: A Patient Buy Where The Entry Is Urgent But The Payoff Isn't (NYSE:LUMN)
· seekingalpha.com
Lumen's EBITDA inflection is expected exiting 2026, with further upside from digital transformation and PCF monetization. Read why LUMN stock is a Buy.
Lumen Technologies ( LUMN ) is down by more than 20% over just the past month, and that opens up an opportunistic Buy setup. The floor appears to be strong enou...